Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MGI-114 in Previously Untreated Advanced Colorectal Cancer
NCT00003786Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Apr 1999
- Primary completion
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irofulven in colorectal cancer (CRC), sponsored by University of Chicago. Planned start Apr 1999; status: withdrawn.
02
Drugs
irofulven
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003786.